在性结肠炎中确定与cuproptosis相关的分子分类和特征基因
Xinyu Bai1,2, Fengrui Zhang3,2, Chan Zhou1,2
1Kunming Medical University, Kunming, China.
Heliyon
|February 5, 2024
概括
性结肠炎是一种编程细胞死亡形式,与性结肠炎 (UC) 有关. 研究人员确定了与UC严重程度相关的与cuproptosis相关的关键基因,为该疾病提供了新的见解.
科学领域:
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症状况,其特征是肠粘膜平衡受损.
- 新发现的一种编程细胞死亡 (PCD) 形式,即cuproptosis,正在成为UC病变的一个重要因素.
研究的目的:
- 研究性结肠炎中与cuproptosis相关的基因 (CRG) 的作用.
- 确定与cuproptosis相关的关键基因 (CRG) 和UC的潜在诊断生物标志物.
主要方法:
- 利用基因表达总量 (GEO) 数据库用于UC相关的基因表达数据.
- 进行了差异表达分析和加权基因共同表达网络分析 (WGCNA).
- 在小鼠模型和UC的临床样本中验证的结果.
主要成果:
- 在UC中鉴定出11个差异表达的cuproptosis相关基因 (DE-CRGs).
- 在UC患者中,FDX1,LIAS和DLAT显著改变,与疾病严重程度相关.
- 在UC小鼠模型和临床样本中,四个特征基因显示mRNA水平下降,表明诊断潜力.
结论:
- 性结肠炎在性结肠炎的病理生理学中起着重要作用.
- 与cuproptosis相关的特定基因可以作为UC诊断和严重程度评估的潜在生物标志物.
- 这些发现为了解cuproptosis在UC中的作用提供了理论基础.
相关概念视频
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
186
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
186
01:29Drugs for Treatment of Ulcerative Colitis in IBD
141
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
141